Temat: "Hydroxyurea" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Role of hydroxyurea therapy in the prevention of organ damage in sickle cell disease: a systematic review and meta-analysis.
Autorzy:: Khargekar N; Department of Haematogenetics, ICMR-National Institute of Immunohaematology, 13th Floor, New MS Building, KEM Hospital Campus, Mumbai, Parel, 400 012, India. .
Banerjee A; Department of Transfusion Transmitted Disease, ICMR-National Institute of Immunohaematology, 13th Floor, New MS Building, KEM Hospital Campus, Mumbai, Parel, 400 012, India.
Athalye S; Department of Transfusion Transmitted Disease, ICMR-National Institute of Immunohaematology, 13th Floor, New MS Building, KEM Hospital Campus, Mumbai, Parel, 400 012, India.
Mahajan N; Department of Haematogenetics, ICMR-National Institute of Immunohaematology, 13th Floor, New MS Building, KEM Hospital Campus, Mumbai, Parel, 400 012, India.
Kargutkar N; Department of Haematogenetics, ICMR-National Institute of Immunohaematology, 13th Floor, New MS Building, KEM Hospital Campus, Mumbai, Parel, 400 012, India.
Tapase P; Department of Paediatric Immunology & Leukocyte Biology, ICMR-National Institute of Immunohaematology, 13th Floor, New MS Building, KEM Hospital Campus, Parel, Mumbai, 400 012, India.
Madkaikar M; Department of Paediatric Immunology & Leukocyte Biology, ICMR-National Institute of Immunohaematology, 13th Floor, New MS Building, KEM Hospital Campus, Parel, Mumbai, 400 012, India.; Pokaż więcej
Źródło:: Systematic reviews [Syst Rev] 2024 Feb 08; Vol. 13 (1), pp. 60. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Hydroxyurea*/therapeutic use
Anemia, Sickle Cell*/complications
Anemia, Sickle Cell*/drug therapy
Humans ; Antisickling Agents/therapeutic use ; Albuminuria/drug therapy ; Blood Transfusion

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Genome instability footprint under rapamycin and hydroxyurea treatments.
Autorzy:: Li J; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.; Université Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France.
Stenberg S; Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
Yue JX; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.; Université Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France.
Mikhalev E; Ginkgo Bioworks, Boston, Massachusetts, United States of America.
Thompson D; Ginkgo Bioworks, Boston, Massachusetts, United States of America.
Warringer J; Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
Liti G; Université Côte d'Azur, CNRS, INSERM, IRCAN, Nice, France.; Pokaż więcej
Źródło:: PLoS genetics [PLoS Genet] 2023 Nov 06; Vol. 19 (11), pp. e1011012. Date of Electronic Publication: 2023 Nov 06 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Hydroxyurea*/pharmacology
Saccharomyces cerevisiae*/genetics
Humans ; Sirolimus/pharmacology ; Mutation ; Genomic Instability/genetics ; DNA, Ribosomal/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Resumption of Spermatogenesis and Fertility Post Withdrawal of Hydroxyurea Treatment.
Autorzy:: Virgous C; Animal Care Facility, Meharry Medical College, 1005 D.B. Todd Blvd, Nashville, TN 37209, USA.
Lyons L; Department of Obstetrics and Gynecology, Meharry Medical College, 1005 D.B. Todd Blvd, Nashville, TN 37208, USA.
Sakwe A; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, 1005 D.B. Todd Blvd, Nashville, TN 37208, USA.
Nayyar T; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, 1005 D.B. Todd Blvd, Nashville, TN 37208, USA.
Goodwin S; Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, 1005 D.B. Todd Blvd, Nashville, TN 37208, USA.
Hildreth J; Department of Microbiology, Immunology and Physiology, Meharry Medical College, 1005 D.B. Todd Blvd, Nashville, TN 37208, USA.
Osteen K; Women's Reproductive Health Research Center, Department of Obstetrics and Gynecology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Bruner-Tran K; Women's Reproductive Health Research Center, Department of Obstetrics and Gynecology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Alawode O; Department of Obstetrics and Gynecology, Meharry Medical College, 1005 D.B. Todd Blvd, Nashville, TN 37208, USA.
Bourne P; Department of Obstetrics and Gynecology, Meharry Medical College, 1005 D.B. Todd Blvd, Nashville, TN 37208, USA.
Hills ER; Department of Obstetrics and Gynecology, Meharry Medical College, 1005 D.B. Todd Blvd, Nashville, TN 37208, USA.
Archibong AE; Department of Obstetrics and Gynecology, Meharry Medical College, 1005 D.B. Todd Blvd, Nashville, TN 37208, USA.; Department of Microbiology, Immunology and Physiology, Meharry Medical College, 1005 D.B. Todd Blvd, Nashville, TN 37208, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 May 27; Vol. 24 (11). Date of Electronic Publication: 2023 May 27.
Typ publikacji:: Journal Article
MeSH Terms:: Hydroxyurea*/adverse effects
Hydroxyurea*/metabolism
Hypogonadism*/drug therapy
Hypogonadism*/metabolism
Female ; Male ; Mice ; Animals ; Sperm Motility ; Semen ; Spermatogenesis ; Testis/metabolism ; Fertility

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Are Genetic Modifiers the Answer to Different Responses to Hydroxyurea Treatment?-A Pharmacogenetic Study in Sickle Cell Anemia Angolan Children.
Autorzy:: Ginete C; H&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1990-096 Lisbon, Portugal.
Delgadinho M; H&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1990-096 Lisbon, Portugal.
Santos B; Centro de Investigação em Saúde de Angola (CISA), Bengo, Angola.; Hospital Pediátrico David Bernardino (HPDB), Luanda, Angola.
Pinto V; H&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1990-096 Lisbon, Portugal.; Centro de Estatística e Aplicações, Universidade de Lisboa (CEAUL), 1749-016 Lisbon, Portugal.
Silva C; H&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1990-096 Lisbon, Portugal.; Centro de Estatística e Aplicações, Universidade de Lisboa (CEAUL), 1749-016 Lisbon, Portugal.
Miranda A; Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA), 1649-016 Lisbon, Portugal.
Brito M; H&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1990-096 Lisbon, Portugal.; Centro de Investigação em Saúde de Angola (CISA), Bengo, Angola.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 May 15; Vol. 24 (10). Date of Electronic Publication: 2023 May 15.
Typ publikacji:: Journal Article
MeSH Terms:: Hydroxyurea*/adverse effects
Anemia, Sickle Cell*/drug therapy
Anemia, Sickle Cell*/genetics
Anemia, Sickle Cell*/complications
Humans ; Pharmacogenomic Testing ; Hemolysis ; Fetal Hemoglobin/analysis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Leveraging mathematical modeling to analyze nonadherence for hydroxyurea therapy in sickle cell disease.
Autorzy:: Pandey A; Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana, USA.
Raja R; Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana, USA.
Estepp JH; Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Agios Pharmaceuticals, Cambridge, Massachusetts, USA.
Ramkrishna D; Davidson School of Chemical Engineering, Purdue University, West Lafayette, Indiana, USA.; Pokaż więcej
Źródło:: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Jun; Vol. 12 (6), pp. 748-757. Date of Electronic Publication: 2023 May 16.
Typ publikacji:: Journal Article
MeSH Terms:: Hydroxyurea*/therapeutic use
Anemia, Sickle Cell*/drug therapy
Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Prognostic value of modified criteria for hydroxyurea resistance or intolerance in patients with high-risk essential thrombocythemia.
Autorzy:: Park YH; Division of Hematology-Oncology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.
Lee S; Division of Hematology-Oncology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.
Mun YC; Division of Hematology-Oncology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.
Park DJ; Department of Laboratory Medicine, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (7), pp. 8073-8082. Date of Electronic Publication: 2023 Jan 09.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Hydroxyurea*/adverse effects
Thrombocythemia, Essential*/diagnosis
Thrombocythemia, Essential*/drug therapy
Adult ; Aged ; Aged, 80 and over ; Humans ; Middle Aged ; Prognosis ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Advanced clinical parameters: A complementary hydroxyurea adherence evaluation in sickle cell anemia treatment.
Autorzy:: Moreira ID; Graduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre/RS, Brazil.
Lessa CLM; Graduate Program in Pathology, Federal University of Health Sciences of Porto Alegre, Porto Alegre/RS, Brazil.
Rocha GLG; Graduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre/RS, Brazil.; Clinicas Hospital of Porto Alegre/RS, Porto Alegre/RS, Brazil.
Schmitz LD; Undergraduate Program in Pharmacy, Federal University of Health Sciences of Porto Alegre, Porto Alegre/RS, Brazil.
Jahnke VS; Vale do Rio dos Sinos University (UNISINOS), Porto Alegre/RS, Brazil.
Fogliatto LM; Graduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre/RS, Brazil.; Graduate Program in Pathology, Federal University of Health Sciences of Porto Alegre, Porto Alegre/RS, Brazil.
Werlang MC; Graduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre/RS, Brazil.
Rotta LN; Graduate Program in Health Sciences, Federal University of Health Sciences of Porto Alegre, Porto Alegre/RS, Brazil.; Pokaż więcej
Źródło:: European journal of haematology [Eur J Haematol] 2022 Dec; Vol. 109 (6), pp. 736-748. Date of Electronic Publication: 2022 Sep 13.
Typ publikacji:: Journal Article
MeSH Terms:: Hydroxyurea*/therapeutic use
Anemia, Sickle Cell*/diagnosis
Anemia, Sickle Cell*/drug therapy
Child ; Adult ; Adolescent ; Humans ; Antisickling Agents/therapeutic use ; Cross-Sectional Studies ; Blood Cell Count

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: The impact of Hydroxyurea on the rates of Vaso-occlusive crises in patients with sickle cell disease in Saudi Arabia: a single-center study.
Autorzy:: Alkhalifah SA; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.
Alanazi M; Department of Pharmacy, King Khalid University Hospital, P.O. Box 3145, Riyadh, 12372, Saudi Arabia.
Almasaoud MA; College of Medicine, King Saud University, Riyadh, 11451, Saudi Arabia.
Al-Malki HS; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.
Al-Murdhi FM; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.
Al-Hazzaa MS; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.
Al-Mufarrij SM; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.
Albabtain MA; College of Medicine, King Saud University, Riyadh, 11451, Saudi Arabia.
Alshiakh AA; College of Medicine, King Saud University, Riyadh, 11451, Saudi Arabia.
AlRuthia Y; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia. .; Pharmacoeconomics Research Unit, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia. .; Pokaż więcej
Źródło:: BMC emergency medicine [BMC Emerg Med] 2022 Nov 29; Vol. 22 (1), pp. 188. Date of Electronic Publication: 2022 Nov 29.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hydroxyurea*/therapeutic use
Anemia, Sickle Cell*/complications
Anemia, Sickle Cell*/drug therapy
Female ; Humans ; Male ; Child ; Saudi Arabia/epidemiology ; Retrospective Studies ; Cognition

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Ten-year longitudinal analysis of hydroxyurea implementation in a pediatric sickle cell program.
Autorzy:: Phan V; Pediatric Specialists of Virginia, Fairfax, Virginia, USA.
Park JA; Inova Fairfax Hospital, Falls Church, Virginia, USA.
Dulman R; Pediatric Specialists of Virginia, Fairfax, Virginia, USA.
Lewis A; Pediatric Specialists of Virginia, Fairfax, Virginia, USA.
Briere N; Pediatric Specialists of Virginia, Fairfax, Virginia, USA.
Notarangelo B; Pediatric Specialists of Virginia, Fairfax, Virginia, USA.
Yang E; Pediatric Specialists of Virginia, Fairfax, Virginia, USA.; Department of Pediatrics, George Washington University School of Medicine, Washington, District of Columbia, USA.; Pokaż więcej
Źródło:: European journal of haematology [Eur J Haematol] 2022 Nov; Vol. 109 (5), pp. 465-473. Date of Electronic Publication: 2022 Sep 02.
Typ publikacji:: Journal Article
MeSH Terms:: Anemia, Sickle Cell*/diagnosis
Anemia, Sickle Cell*/drug therapy
Anemia, Sickle Cell*/epidemiology
Hydroxyurea*/therapeutic use
Antisickling Agents/therapeutic use ; Blood Transfusion ; Child ; Erythrocytes, Abnormal ; Fetal Hemoglobin ; Humans ; Infant

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Hydroxyurée : pourquoi et comment l'utiliser chez l'enfant atteint de drépanocytose ?
Autorzy:: Pondarré, Corinne (AUTHOR)
Soulié, Alizée (AUTHOR); Pokaż więcej
Źródło:: Hematologie. nov/dec2023, Vol. 29 Issue 6, p354-364. 11p.

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Hydroxyurea"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji